Pyridostigmine
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 3026 publications
Longitudinal overview of symptomatic and immunosuppressive drugs in LEMS.
Journal: Journal of neuromuscular diseases
Published: August 17, 2026
Accuracy of Antibody Testing in Myasthenia Gravis: The ADAM Study.
Journal: Neurology
Published: August 11, 2026
Ipilimumab/nivolumab-induced severe triple M syndrome in a patient with metastatic renal cancer.
Journal: The British journal of cardiology
Published: July 29, 2026
Benefit of Salbutamol for the Treatment of Neuromuscular Junction Dysfunction in Patients With Purine-Rich Element Binding Protein A (PURA) Syndrome.
Journal: Cureus
Published: July 16, 2026
Single-Dose Nivolumab as a Trigger of Myocarditis, Myositis, and Myasthenia Gravis Overlap Syndrome With Late Cardiac Death Despite Initial Recovery: A Case Report.
Journal: The American journal of case reports
Published: July 14, 2026
Transient Neonatal Myasthenia Gravis in a Newborn Infant Presenting to an Emergency Department.
Journal: Cureus
Published: July 12, 2026
Medication use trajectories in myasthenia gravis pregnancies: a population-based drug utilization study.
Journal: Journal of neurology
Published: June 30, 2026
Suspected Adult-Onset Congenital Myasthenic Syndrome Associated With a Heterozygous CHRND Variant in a Patient With Seropositive Rheumatoid Arthritis: A Case Report.
Journal: The American journal of case reports
Published: June 22, 2026
A lichenoid drug eruption secondary to pyridostigmine.
Journal: JAAD case reports
Published: June 22, 2026
Last Updated: 09/26/2026